Results for tag: "Procarbazine"

Procarbazine is an oncology drug used to treat Hodgkin's lymphoma, a type of cancer that affects the lymphatic system. It is a monoamine oxidase inhibitor, meaning it works by blocking the action of an enzyme that breaks down certain neurotransmitters. Procarbazine is usually administered orally or intravenously, and is often used in combination with other drugs to treat Hodgkin's lymphoma. It is also used to treat other types of cancer, such as brain tumors and melanoma. Procarbazine is generally well-tolerated, but can cause side effects such as nausea, vomiting, and hair loss. It is important to monitor blood counts and liver function while taking this drug. The procarbazine market is an important part of the oncology drug market, as it is used to treat a variety of cancers. It is a relatively safe and effective drug, and is often used in combination with other drugs to treat cancer. Some companies in the procarbazine market include Bristol-Myers Squibb, Pfizer, and Merck. Show Less Read more